Target intelligence / Profile preview

Immunoglobulin lambda variable 3-10 (IGLV3-10)

Target
IGLV3-10
Molecular classification
Immunoglobulin variable domain, Antibody component, Other
01

Overview

Immunoglobulin lambda variable 3-10 is a member of the immunoglobulin lambda light chain variable region gene family. It encodes the variable part of the N-terminal domain of the light chain, which, together with the variable domain of the heavy chain, forms the antigen-binding site of antibodies. During B cell development, the locus undergoes V-(D)-J recombination, generating diversity necessary for antigen recognition in humoral immunity. The variable region gene is transcribed and incorporated into immunoglobulin molecules produced by B lymphocytes and plasma cells, enabling the adaptive immune response to a wide range of antigens

Other names
IGLV3-10IGLV310V2-7Immunoglobulin lambda variable 3-10
02

Mechanism of action

Not applicable for traditional drugs. The encoded variable region participates in antigen binding as part of antibodies generated by B cells. Therapeutic monoclonal antibodies would utilize similar sequences but do not target IGLV3-10 specifically

03

Biological functions

Antigen recognitionHumoral immune responseComponent of immunoglobulin complex
04

Disease associations

OtherAutism spectrum disorder
05

Safety considerations

None specific. Being part of immune system genes, aberrant recombination or somatic mutation can lead to lymphoid malignancies, but IGLV3-10 itself does not have recognized therapeutic safety issues

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-10 (IGLV3-10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-10 (IGLV3-10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call